sa¹ú¼Ê´«Ã½

Skip to content
Join our Newsletter

Alberta health minister signs onto federal deal for rare disease drugs

EDMONTON — Alberta Health Minister Adriana LaGrange has signed a deal with her federal counterpart to expand access to medication for people with rare diseases.
fd7cf43f50e295fe2e494458cf10fc513779be2d4c8a2bc6d0cd1c6769b27591
Adriana LaGrange, Minister of Health for Alberta, makes a health care announcement in Calgary on Dec. 21, 2023. THE CANADIAN PRESS/Todd Korol

EDMONTON — Alberta Health Minister Adriana LaGrange has signed a deal with her federal counterpart to expand access to medication for people with rare diseases.

LaGrange joined federal Health Minister Mark Holland in Edmonton to announce millions in spending on both emerging and proven drugs, as well as on diagnostics and screening.

The drugs include Poteligeo for treating Sézary syndrome, Oxlumo for hyperoxaluria type 1 and Epkinly for large B-cell lymphoma.

LaGrange says the move will help support Albertans living with rare diseases and open the door to potentially life-changing treatments.

Holland says the deal is a step toward building a stronger public health system for Albertans and aims to give Albertans with rare diseases the "best health outcomes possible."

Alberta is the third province behind sa¹ú¼Ê´«Ã½ and Newfoundland and Labrador to sign onto a federal deal under the National Strategy for Drugs for Rare Diseases.

This report by The Canadian Press was first published Dec. 5, 2024.

Aaron Sousa, The Canadian Press